Program - Wednesday, July 4

Print
Please click on the relevant day to view the applicable detailed program.

  Wednesday, July 4  
Tuesday, July 3 Thursday, July 5
HALL A
08:00-09:00
SESSION 15 | HIGH RISK PROSTATE CANCER
 Chairpersons Manfred Wirth, Germany | Zohar Dotan, Israel 
08:00-08:15


08:15-08:30


08:30-08:45


08:45-09:00
Aggressive and unusual subtypes of Prostate Cancer
Jonathan Epstein, USA

Optimizing the management of High Risk Prostate Cancer with Radiotherapy
Michael Zelefsky, USA

The role of Radical Prostatectomy in Locally Advanced and Oligometastatic High Risk Prostate Cancer
Manfred Wirth, Germany

Novel Targeted Androgen Ablation Prior to Radical Prostatectomy
Adam Kibel, USA
 
09:00-10:30
SESSION 18 | PROSTATE CANCER: ADT AND CARDIOVASCULAR RISK
 Chairpersons Jehonathan Pinthus, Canada | David Margel, Israel
09:00-09:10


09:10-09:20


09:20-09:30


09:30-09:40


09:40-09:50


09:50-10:10
09:50-10:00
10:00-10:10

10:10-10:20


10:20-10:30
Epidemiology: The RADICAL PC Trial
Jehonathan Pinthus, Canada

Mechanism: How ADT accelerates CVD
Bertrand Tombal, Belgium

FSH as a modulator of CVS events in ADT recipients
Jehonathan Pinthus, Canada

Testosterone and Cardiovascular Mortality
Claude Schulman, Belgium

Intermittent vs. Continuous ADT
Laurence Klotz, Canada

Agonists vs. Antagonists: should Antagonists be the primary choice for ADT?
No: Igor Tsaur, Germany
Yes: David Margel, Israel

Statin use in Prostate Cancer
Ilan Leibovitch, Israel

Is there a "Cardio-friendly" ADT?
Bertrand Tombal, Belgium
 
10:30-11:00
Coffee Break and Poster Viewing
 
11:00-12:15
SESSION 21 | MUSCLE INVASIVE BLADDER CANCER 
 Chairpersons Mark Soloway, USA | Gilad Amiel, Israel
11:00-11:20


11:20-11:40
11:20-11:35
11:35-11:40

11:40-12:00


12:00-12:15
Prostate sparing cystectomy: Functional and Oncological Results
Jehonathan Pinthus, Canada

Robotic assisted radical cystectomy
Alejandro Rodriguez, USA
Comments: Mark Soloway, USA

Neoadjuvant treatment: What's new? Do we agree to it in 2018?
Mitchell Benson, USA
 
Trimodal Therapy for MIBC:
Adam Feldman, USA
 
12:15-13:15
SESSION 24 | HONORARY GUEST SPEAKER LECTURE (Hall A)
Chairperson
Jacob Ramon, Israel
  The Future of Human Memory
Yadin Dudai, Israel
Global Distinguished Professor of Neuroscience
Neurobiology Professor at the Weizmann Institute of Science
 
13:15-14:00
Lunch Break and Poster Viewing
 
14:00-15:15
SESSION 25 | RENAL CELL CARCINOMA
 Chairpersons Gennady Bratslavsky, USA | Ofer Nativ, Israel 
14:00-14:15


14:15-14:30


14:30-14:45


14:45-15:00


15:00-15:15
Pattern and implication of lymphatic drainage in renal tumors
Axel Bex, The Netherlands

Molecular pathology of RCC
Evgeny Yakirevich, USA

Molecular profiling of RCC: Timeless Lessons
Gennady Bratslavsky, USA

Active surveillance in RCC
Marc-Olivier Timsit, France

Hereditary RCC
Evgeny Yakirevich, USA
 
15:15-16:30
SESSION 28 | METASTATIC RENAL CELL CARCINOMA: CYTOREDUCTIVE NEPHRECTOMY
 Chairpersons  Axel Bex, The Netherlands | Avishay Sella, Israel
15:15-15:30


15:30-15:45



15:45-16:00


16:00-16:15


16:15-16:30
Cytoreductive Nephrectomy in the Tyrosine kinase inhibitors era: The CARMENA Study
Arnaud  Méjean, France

Cytoreductive Nephrectomy in mRCC patients:
Is it still required in the combined targeted and immunotherapy era
Axel Bex, The Netherlands
 
Is the timing of Cytoreductive Nephrectomy important?
Marc-Olivier Timsit, France

Benefits of Cytoreductive Nephrectomy: Reflection of surgery or surgeon’s bias?
Gennady Bratslavsky, USA

Discussion
 
16:30-17:00
Coffee Break and Poster Viewing
 
17:00-18:30
SESSION 31 | RENAL CELL CARCINOMA SURGERY
 Chairpersons  Ari Hakimi, USA | Alexander Tsivian, Israel
17:00-17:20
17:00-17:10
17:10-17:20

17:20-17:35


17:35-17:55
17:35-17:45
17:45-17:55

17:55-18:10


18:10-18:30
Positive surgical margins in partial nephrectomy specimen
Pathologist view: Evgeny Yakirevich, USA
Urologist view: Ofer Nativ, Israel

Perioperative systemic therapy in locally advanced RCC
Ari Hakimi, USA

RCC and IVC Thrombus
Robotic: Alexandre Mottrie, Belgium

RCC with level IV Caval thrombus
Markus Hohenfellner, Germany

Retroperitoneal Partial Nephrectomy: when, why and how
Claude Abbou, France
 
HALL B
08:00-09:00
SESSION 16 | FUNCTIONAL UROLOGY: STRESS URINARY INCONTINENCE IN WOMEN
 Chairperson Dmitry Pushkar, Russia | Ilan Gruenwald, Israel
08:00-08:15


08:15-08:45
08:15-08:25
08:25-08:35
08:35-08:45

08:45-09:00
Are Bulking Agents making a comeback in the treatment of SUI?
Howard Goldman, USA

No Mesh repair of SUI:
Jacques Corcos, Canada
Howard Goldman, USA
Conclusions: Dmitry Pushkar, Russia

How to treat SUI in women with Detrusor Underactivity
Dmitry Pushkar, Russia
Ilan Gruenwald, Israel
 
09:00-10:30
SESSION 19 | FUNCTIONAL UROLOGY
 Chairpersons Polina Reyblat, USA | Michael Vainrib, Israel 
09:00-09:30




09:30-09:50



09:50-10:00
10:00-10:10



10:10-10:30
Urodynamics:
The reliability of urodynamic parameters as predictors of a "hostile bladder" in the neurogenic population
Moderator: Jacob Golomb, Israel
Panelists: Polina Reyblat, USA | Dmitry Pushkar, Russia | Kobi Stav, Israel | Ilan Gruenwald, Israel

OAB:
Devices and novel Technologies for the treatment of OAB
Howard Goldman, USA
 
Antimuscarinic - resistant OAB:
Sacral Neuromodulation: Dean Elterman, Canada
Botolinium Toxin: Noam Kitrey, Israel

Surgery:
Surgery for Pelvic Organ Prolapse:
Is Hysterectomy required?
Robotic surgery: Advances and long term results
 
10:30-11:00
Coffee Break and Poster Viewing
 
11:00-12:15
SESSION 22 | RADIO-RECURRENT PROSTATE CANCER
 Chairpersons  Michael Zelefsky, USA | Zvi Symon, Israel
11:00-11:10


11:10-11:20


11:20-11:40
11:20-11:30
11:30-11:40

11:40-11:50


11:50-12:00


12:00-12:10


12:10-12:15
Role of Salvage Radiotherapy
Michael Zelefsky, USA

Role of Salvage Brachytherapy
TBA

Salvage Radical Prostatectomy
Open: Manfred Wirth, Germany
Robotic: Senthil Nathan, UK

Salvage LN Dissection
Jonathan Coleman, USA

Cryoablation
Bernard Malavaud, France

VTP (Tookad)
Jonathan Coleman, USA

Discussion
 
12:15-13:15 SESSION 24 | HONORARY GUEST SPEAKER LECTURE (Hall A)
Chairperson
Jacob Ramon, Israel
  The Future of Human Memory
Yadin Dudai, Israel
Global Distinguished Professor of Neuroscience
Neurobiology Professor at the Weizmann Institute of Science
 
13:15-14:00
Lunch Break and Poster Viewing
 
14:00-15:15
SESSION 26 | NON MUSCLE INVASIVE BLADDER CANCER (NMIBC)
 Chairpersons Bernard Malavaud, France | Amnon Zisman, Israel 
14:00-14:15
14:00-14:10
14:10-14:15

14:15-14:30
14:15-14:25
14:25-14:30

14:30-14:45
14:30-14:40
14:40-14:45

14:45-15:05
14:45-14:55
14:55-15:05

15:05-15:15
Critical evaluation of perioperative single dose intravesical chemotherapy in NMIBC
Comments: Seth Lerner, USA

En Bloc TURBT
Comments: Mark Soloway, USA

EAU/SUO Guidelines on Low Grade NMIBC may lead to overtreatment
Mark Soloway, USA
Comments: James N'Dow, UK

BCG Refractory NMIBC:
Intravesical Docetaxel: Mitchell Benson, USA
(RITE) Thermo-chemotherapy: Ullrich Witzsch, Germany
 
There is a role for Check Point Inhibitors in NMIBC
 
15:15-16:30
SESSION 29 | GENOMICS AND GENETICS IN PROSTATE CANCER
 Chairpersons Neil Fleshner, Canada | Nicola Mabjeesh, Israel
15:15-15:30


15:30-15:45


15:45-16:00


16:00-16:15


16:15-16:30
Genetics and Genomics on whom to biopsy, whom to re-biopsy and whom to treat
Adam Kibel, USA

Role of Germline genomics in detection and treatment
Neil Fleshner, Canada

The role of Genetic Testing for Inherited Prostate Cancer Risk
Leonard Gomella, USA

Using Genomics for selection of Salvage Radiotherapy
Vedang Murthy, India

Implementation of prostate cancer biomakers in daily practice: Are they cost-effective and useful for patient selection
Derya Tilki, Germany
 
16:30-17:00
Coffee Break and Poster Viewing
 
 17:00-18:30 SESSION 32 | ENDOUROLOGY
 Chairpersons Scott Hubosky, USA | Mario Sofer, Israel
17:00-17:30



17:30-17:45


17:45-18:00



18:00-18:15


18:15-18:30
Management of ureteral complications in renal transplant: Endoscopic vs. Surgical
Endoscopy: David Goldfarb, USA
Surgery: Marc-Olivier Timsit, France

Treatment of intractable nephrolithiasis with renal autotransplantation
Stuart Flechner, USA

URS is indicated in every patient with a suspected Upper Tract Urothelial Tumor
Agree: Scott Hubosky, USA
Disagree: Rachel Schor, Israel

Does stent insertion in mBC induce upper tract TCC?
Ofer Shenfeld, Israel

Mini PCNL
For: Mordechai Duvdevani, Israel
Against: Mario Sofer, Israel
 
HALL C
08:00-09:00
SESSION 17 | BPH
 Chairpersons Dean Elterman, Canada | Alexander Greenstein, Israel
08:00-08:15


08:15-08:30


08:30-08:45


08:45-09:00
Cialis for BPH: What is the evidence in 2018?
Gil Meyer, Israel

The Cost Conundrum of Generic BPH Drugs
Benjamin Davies, USA

Injectable therapy with Fexapotide Triflutate (FT) for BPH
Ivan Grunberger, USA

Modern technologies for BPH
Dean Elterman, Canada
 
09:00-10:30
SESSION 20 | TESTICULAR CANCER
 Chairpersons Joel Sheinfeld, USA | Jack Baniel, Israel
09:00-09:15


09:15-09:35
09:15-09:25
09:25-09:35

09:35-09:50


09:50-10:05


10:05-10:20


10:20-10:30
The case against modified RPLND templates for Testicular Cancer
Joel Sheinfeld, USA

Robotic RPLND is as good as open RPLND:
Yes: Alejandro Rodriguez, USA
No: Joel Sheinfeld, USA

Stage 1 Germ Cell Tumor: Is any adjuvant still needed?
Nicolas Mottet, Israel

Late toxicity including secondary malignancy after therapy of testicular cancer
Raphael Pfeffer, Israel

Late relapse of Testicular Cancer
Peter Albers, Germany

Incidental Testicular Tumors during Infertility workup
Edouard Amar, France
 
10:30-11:00
Coffee Break and Poster Viewing
 
11:00-12:15
SESSION 23 | CASTRATE RESISTANT PROSTATE CANCER (CRPC)
 Chairpersons Igor Tsaur, Germany | David Sarid, Israel
11:00-11:40
11:00-11:10
11:10-11:20
 
11:20-11:40

11:40-12:00


12:00-12:15
Asymptomatic mCRPC must be treated:
For: Urologist: Michael Haifler, Israel
For: Oncologist: Avivit Peer, Israel

Against:
 Bertrand Tombal, Belgium

Ongoing trials that might change the standard of care
Igor Tsaur, Germany

Opioid treatment mCRPC and Surgical therapy: Are we helping or harming
Benjamin Davies, USA
 
12:15-13:15
SESSION 24 | HONORARY GUEST SPEAKER LECTURE (Hall A)
Chairperson  Jacob Ramon, Israel
 
The Future of Human Memory
Yadin Dudai, Israel
Global Distinguished Professor of Neuroscience
Neurobiology Professor at the Weizmann Institute of Science
 
13:15-14:00
Lunch Break and Poster Viewing
 
14:00-15:15
SESSION 27 | FUNCTIONAL UROLOGY
 Chairpersons Jacques Corcos, Canada | Shachar Aharony, Israel
14:00-14:30




14:30-15:15
The challenges of treating SUI in obese women
Moderator: Nirit Rosenblum, USA
Panelists: Jacques Corcos, Canada | Dean Elterman, Canada | Dimitry Pushkar, Russia | Yoram Vardi, Israel | Jacob Golomb, Israel

Troubleshooting and pitfalls during Urodynamic assessment 
Moderator: Jacques Corcos, Canada
Panelists: Shachar Aharony, Israel | Kobi Stav, Israel  | Michael Vainrib, Israel | Ilan Gruenwald, Israel
Polina Reyblat, USA | Dean Elterman, Canada
15:15-16:30
SESSION 30 | PEDIATRIC UROLOGY: DISORDERS OF SEXUAL DIFFERENTIATION (DSD)
 Chairpersons  Eugene Minevich, USA | Boris Chertin, Israel
15:15-15:35


15:35-16:30
A DSD Team Project
Guy Hidas, Israel

DSD Case Studies
Moderator: David Ben Meir, Israel
Panelists: Jacob Ben Chaim, Israel | Boris Chertin, Israel | Yoram Mor, Israel | Sarel Halachmi, Israel | Eugene Minevich, USA | Martin Koyle, Canada
 
16:30-17:00
Coffee Break and Poster Viewing